Early AFP (≤24 years) (17.1% versus 44.4%, p < 0.001), and high parity (≥5) (1.3% versus 9.7%, p < 0.001) were more frequent in postmenopausal breast cancer patients (Table 1). This evidence concerns the gene AFP and breast cancer.